261 related articles for article (PubMed ID: 31097328)
1. The motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytes.
Arif E; Solanki AK; Srivastava P; Rahman B; Tash BR; Holzman LB; Janech MG; Martin R; Knölker HJ; Fitzgibbon WR; Deng P; Budisavljevic MN; Syn WK; Wang C; Lipschutz JH; Kwon SH; Nihalani D
Kidney Int; 2019 Jul; 96(1):139-158. PubMed ID: 31097328
[TBL] [Abstract][Full Text] [Related]
2. Targeting myosin 1c inhibits murine hepatic fibrogenesis.
Arif E; Wang C; Swiderska-Syn MK; Solanki AK; Rahman B; Manka PP; Coombes JD; Canbay A; Papa S; Nihalani D; Aspichueta P; Lipschutz JH; Syn WK
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1044-G1053. PubMed ID: 33908271
[TBL] [Abstract][Full Text] [Related]
3. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
4. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
[TBL] [Abstract][Full Text] [Related]
6. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
7. SMAD3-dependent and -independent pathways in glomerular injury associated with experimental glomerulonephritis.
Ghayur A; Padwal MK; Liu L; Zhang J; Margetts PJ
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F152-F162. PubMed ID: 31141397
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
10. Motor protein Myo1c is a podocyte protein that facilitates the transport of slit diaphragm protein Neph1 to the podocyte membrane.
Arif E; Wagner MC; Johnstone DB; Wong HN; George B; Pruthi PA; Lazzara MJ; Nihalani D
Mol Cell Biol; 2011 May; 31(10):2134-50. PubMed ID: 21402783
[TBL] [Abstract][Full Text] [Related]
11. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
13. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.
Finer G; Schnaper HW; Kanwar YS; Liang X; Lin HY; Hayashida T
Kidney Int; 2012 Sep; 82(5):525-36. PubMed ID: 22534961
[TBL] [Abstract][Full Text] [Related]
14. Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria.
Liang X; Schnaper HW; Matsusaka T; Pastan I; Ledbetter S; Hayashida T
PLoS One; 2016; 11(5):e0155534. PubMed ID: 27187580
[TBL] [Abstract][Full Text] [Related]
15. TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression.
Liu L; Lin W; Zhang Q; Cao W; Liu Z
J Mol Med (Berl); 2016 Mar; 94(3):291-300. PubMed ID: 26432290
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
17. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.
Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T
J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Kidney Fibrosis.
Yokoi H; Mukoyama M
Methods Mol Biol; 2017; 1489():431-443. PubMed ID: 27734395
[TBL] [Abstract][Full Text] [Related]
19. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
[TBL] [Abstract][Full Text] [Related]
20. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
